Deletion of microRNA miR-146a does not prevent streptozotocin-induced murine autoimmune type 1 diabetes

Diabetes Metab. 2016 Nov;42(5):372-373. doi: 10.1016/j.diabet.2016.03.007. Epub 2016 Apr 25.

¹ Shandong Provincial Key Laboratory of Metabolic Disease, the Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China; Henry Ford Immunology Program, Departments of Dermatology and Internal Medicine, Henry Ford Health System, 1, Ford Place, 48202 Detroit, MI, United States; Department of Dermatology, Henry Ford Health System, 48202 Detroit, MI, United States.
² Henry Ford Immunology Program, Departments of Dermatology and Internal Medicine, Henry Ford Health System, 1, Ford Place, 48202 Detroit, MI, United States; Department of Dermatology, Henry Ford Health System, 48202 Detroit, MI, United States.
³ Shandong Provincial Key Laboratory of Metabolic Disease, the Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China.
⁴ Henry Ford Immunology Program, Departments of Dermatology and Internal Medicine, Henry Ford Health System, 1, Ford Place, 48202 Detroit, MI, United States; Department of Dermatology, Henry Ford Health System, 48202 Detroit, MI, United States; Department of Internal Medicine, Henry Ford Health System, 48202 Detroit, MI, United States.
⁵ Henry Ford Immunology Program, Departments of Dermatology and Internal Medicine, Henry Ford Health System, 1, Ford Place, 48202 Detroit, MI, United States; Department of Dermatology, Henry Ford Health System, 48202 Detroit, MI, United States; Department of Internal Medicine, Henry Ford Health System, 48202 Detroit, MI, United States. Electronic address: [email protected].

No abstract available

Keywords: Beta-cells; MicroRNAs; Streptozotocin; Type 1 diabetes; miR-146a.

Publication types